Topics tagged rct

Topic	Replies	Views	Activity
Use of percentage change in clinical trials effect-measures , rct , interpretation	16	542	April 8, 2024
Run-in phase in RCTs research methods rct	14	9634	April 1, 2024
Individual response data analysis design , interpretation , rct	236	34258	March 24, 2024
Communicating statistical concerns to the FDA design , rct , regulatory	3	364	March 11, 2024
Is Lithium Equivalent to Lecanemab in Slowing cognitive decline in Alzheimer's Disease? research methods survival-analysis , interpretation , rct	0	340	February 23, 2024
Prior design in a bayesian re-analysis of an RCT bayes rct	1	234	February 19, 2024
Assessing correlation/surrogacy between 2 estimated treatment effects data analysis meta-analysis , surrogate , rct	9	438	February 17, 2024
Review of Trial at the Center of the Firestorm Over Early Connection of Patients to Ventilators during the Pandemic measurement design , interpretation , rct	34	2828	February 16, 2024
RCT: protocol deviation and implications for analysis research methods rct	6	333	February 16, 2024
Time to pre-randomization monthly seizure count design , survival-analysis , rct	1	157	February 8, 2024
ITT analysis population - RCT design rct	6	774	February 3, 2024
Ranked analysis of ANCOVA modeling strategy design , interpretation , rct	7	567	January 21, 2024
Bayesian Dynamic Borrowing with Robust Mixture Priors: Fair or not? bayes , rct	7	405	January 18, 2024
Language for communicating frequentist results about treatment effects study interpretation confidence-interval , rct , p-value , journal , writing	200	108651	January 9, 2024
Substituting treatment arm with drug exposure (continuous variable) in RCT research methods rct	10	461	January 8, 2024
Encryption of dataset in REDCap data analysis rct , data-management	3	410	December 15, 2023
Mixed models modelling models random-effects , rct	14	1146	October 26, 2023
Summary Statistics vs Raw Data measurement time-to-event , ordinal , rct , multiple-endpoints , critical-care	9	9005	October 23, 2023
Comparing "all active dose" to placebo - do we treat "all active dose" as one group or separate groups? models design , rct , interpretation	2	575	September 4, 2023
Guidance of analysis of longitudinal patient reported outcomes w.r.t Joint models modeling strategy longitudinal , rct , interpretation	4	671	August 29, 2023
Effect modification in series of n-of-1 trials (repeated crossover) modeling strategy rct	2	445	August 25, 2023
Data collected outside of guidelines/window rct	10	1017	June 13, 2023
Different results in unconstrained partial proportional odds model modeling strategy bayes , ordinal , rct	0	693	May 22, 2023
Attrition Sensitive Randomisation design , randomization , missing-data , rct	1	916	April 25, 2023
Randomization in a diagnostic study - necessary? design design , rct	3	932	March 16, 2023
Appropriate model for combined data from two RCTs modeling strategy rct	10	740	March 8, 2023
RCT with missing follow-up outcomes: ANCOVA + MI vs Mixed-Effects Modelling? strategy , missing-data , rct	50	5102	March 7, 2023
FDA "Bad Habits" drug development interpretation , rct	7	1887	March 4, 2023
Resources for handling blocked randomization in the analysis of RCTs modeling strategy rct	10	1301	February 11, 2023
Toward Guidelines for RCT Measurements.. What are the characteristics of an acceptable measurement for RCT? data analysis design , measurement , rct	0	912	February 10, 2023